Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

NATIONAL TRAUMA INSTITUTE OVERVIEW
NTI SEEKS TO STOP THE BLEEDING WITH DRAMATIC CAMPAIGN IN TIMES SQUARE



NTI launched a powerful giving campaign in the heart of New York City on July 15. In a city that witnessed one of the most significant traumatic events in our nation’s history, NTI hopes to strike a chord with “Stop the Bleeding,” a call to support vastly underfunded trauma research in hemorrhage, or massive bleeding.


Read the press release.

The National Trauma Institute (NTI) is a non-profit organization dedicated to funding and developing research that addresses trauma injury in the United States. Trauma –including that sustained in car crashes, domestic violence, accidents, assaults and natural disasters—is at epidemic levels in the United States.

Yet, it receives only a tiny fraction of the country’s research dollars.

NTI works to assemble a critical mass of funds from a variety of public and private sources in order to award large-scale research grants to projects with the promise to advance clinical practice, save lives and reduce disability. We also foster the sharing of medical knowledge between civilian and military trauma experts.

Our priorities span the continuum of care from pre-hospital (first responders) to recovery and rehabilitation, and we set a research agenda each year to address the areas of most pressing need. Our current research priority areas are:

    Hemorrhage
    Infection
    Disaster Preparedness

    Burns
    Airway and ventilation strategies
    Technology Development


























This year, 170,000 Americans will die from a traumatic injury. Trauma is the #1 cause of death for children and adults ages 1 to 44.



Hemorrhage, or massive bleeding, is responsible for
nearly half of those deaths and for the majority of preventable deaths of our soldiers in Iraq
and Afghanistan.

Several medical solutions have the potential to control massive bleeding, but without adequate funding for further development and clinical trials, life-saving treatments are elusive dreams.

Help Fund Hemorrhage Research Today, and Stop the Bleeding.